According to Transparency Market Research’s latest report on the global flowable hemostats market for the historical period 2017–2018 and forecast period 2019–2027, rise in number of trauma and surgical cases is projected to drive the global flowable hemostats market during the forecast period
According to the report, the global flowable hemostats market was valued at ~US$ 700 Mn in 2018 and is anticipated to expand at a CAGR of ~6% from 2019 to 2027
Rise in Number of Trauma and Surgical Cases: Key Driver
- Increase in global trauma and accident cases is a major driver of the global flowable hemostats market
- According to the World Health Organization (WHO), an estimated 1.25 million people lose their lives in road traffic accidents across the world every year
- Globally, hemorrhage or excessive bleeding is responsible for over one third of pre-hospital deaths and over 40% of deaths within the first 24 hours
- Moreover, a study conducted by the U.S. Armed Forces suggested that 25% of battlefield fatalities are medically preventable. Nearly 90% of these deaths are due to uncontrolled blood loss.
- Such high number of deaths has induced governments to develop and provide better hemorrhage control systems
- The patient pool with trauma and different chronic diseases is also rising rapidly across the world. This is likely to increase the number of surgical procedures, consequently propelling the global flowable hemostats market.
Request a sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=49347
Increase in Global Geriatric Population Boosts Market Growth
- Increase in the global geriatric population is projected to fuel the demand for hemostats, including flowable hemostats during the forecast period. Rise in geriatric population directly affects the demand for hemostats, primarily due to higher susceptibility to various diseases among the population leading to higher number of surgeries.
- The global geriatric population is increasing rapidly. According to the WHO, the global geriatric population is expected to increase from 524 million in 2010 to 1.5 billion by 2050. Aging increases the need of healthcare, as it renders people prone to cardiovascular diseases such as coronary heart disease, respiratory diseases such as TB and pneumonia, dental caries & oral cancer, and orthopedic conditions such as osteoporosis.
- Most developed countries have high geriatric population. According to the WHO, the geriatric population is expected to rise at a rapid pace in developed countries such as the U.S., the U.K., and Japan.
- Access to various diagnostic and treatment services has improved due to favorable healthcare policies and advancement in healthcare facilities in countries such as the U.S., Japan, the U.K., and other countries in Western Europe. This in turn has increased life expectancy of the population. Increase in geriatric population is anticipated to propel the global flowable hemostats market during the forecast period.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=49347
Lack of Awareness in Developing Countries to Hamper Market
- Bleeding disorders account for a significant share of the disease burden in developing countries
- Von Willebrand disease (VWD) is the most common bleeding disorder across the world. According to Health Grades, Inc., about 3 million people with VWD go undiagnosed globally each year. Prevalence of Von Willebrand disease is high in developing countries such as China and India.
- Lack of awareness about bleeding disorders in developing countries is expected to hamper the global flowable hemostats market during the forecast period
Request a custom report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=49347
Flowable Hemostats Market: Competition Landscape
- This report profiles major players in the global flowable hemostats market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
- The global flowable hemostats market is highly consolidated, with the presence of small number of players
- Major players operating in the global flowable hemostats market are Johnson & Johnson, Baxter International, Inc., and Teleflex Incorporated
- The report on the global flowable hemostats market discussed individual strategies, followed by company profiles of manufacturers of flowable hemostats. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global flowable hemostats market.
About Transparency Market Research
Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research firm that offers market analysis reports and business consulting. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit our YouTube channel –
https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact Us:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: 1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]